Accendra Health, Inc. cash flow to debt ratio of -4.56% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Accendra Health, Inc.'s free cash flow has decreased 354.67% from $-66.67M last year to $-303.12M, signaling decreasing performance

Accendra Health, Inc.'s debt to equity ratio is -3.23, signaling that the company spent its equity and risk bankruptcy.

Accendra Health, Inc.'s debt to equity ratio is -3.23, signaling that the company spent its equity and risk bankruptcy.

Accendra Health, Inc. has a net debt to EBITDA ratio of 8.88x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

Accendra Health, Inc.'s interest coverage ratio is 0.77, which means that the company struggles to meet interest obligations, signaling financial risk.

Accendra Health, Inc.'s profit margin has decreased (236.75%) in the last year from -3.39% to -11.41%, signaling decreasing performance

Accendra Health, Inc.'s short-term liabilities of $947.08M exceed its short-term assets of $547.87M, signaling financial risk

Accendra Health, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Accendra Health, Inc.'s return on equity of 63.40%, is higher than 15.00%, indicating good performance

Accendra Health, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Accendra Health, Inc. had positive net income in only 2 out of 5 years, indicating unstable earnings

Accendra Health, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Accendra Health, Inc. has negative free cash flow, indicating cash burn

Accendra Health, Inc.'s yearly earnings has decreased 203.47% since last year from $-362.69M to $-1.10B, signaling decreasing performance

Accendra Health, Inc.'s yearly revenue has decreased 74.19% since last year from $10.70B to $2.76B, signaling decreasing performance

ROIC 6.36% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Accendra Health, Inc.'s 3-year revenue CAGR of -34.78% is negative, indicating declining revenue over the past 3 years

Accendra Health, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Accendra Health, Inc. had positive ROE in only 2 out of 5 years, indicating inconsistent returns on equity

Accendra Health, Inc. has insufficient data to evaluate this check.

Accendra Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Accendra Health, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Accendra Health, Inc. has an EV/EBITDA ratio of 9.37x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Accendra Health, Inc. is undervalued relative to its fair value price of 4.55 based on Earnings Fair Value model

Accendra Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Accendra Health, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

Accendra Health, Inc. has a price-to-sales ratio of 0.04x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue